Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cells (scientific article published on 06 April 2016)

Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.

Q50591990

Inflammatory phase of bone healing initiates the regenerative healing cascade.

Q52893841

Expansion of murine periosteal progenitor cells with fibroblast growth factor 2 reveals an intrinsic endochondral ossification program mediated by bone morphogenetic protein 2.

Q53037265

Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis.

Q54611057

Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers

Q57679356

Hip fracture in rheumatoid arthritis

Q58135954

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

Q27860872

Indian hedgehog in the late-phase differentiation in mouse chondrogenic EC cells, ATDC5: upregulation of type X collagen and osteoprotegerin ligand mRNAs

Q28585657

The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients

Q34474506

Mechanical loading reduces inflammation-induced human osteocyte-to-osteoclast communication.

Q35817284

Regenerative effects of transplanted mesenchymal stem cells in fracture healing

Q36185562

Drugs and fracture repair

Q36392934

Inhibition of fracture healing

Q37023567

Evidence that cytokines play a role in rheumatoid arthritis

Q37316594

Bone loss in inflammatory disorders

Q37483151

Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.

Q37484520

Humanized culture of periosteal progenitors in allogeneic serum enhances osteogenic differentiation and in vivo bone formation

Q37585427

Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Q37910408

Fracture healing under healthy and inflammatory conditions

Q37980336

ATDC5: an excellent in vitro model cell line for skeletal development

Q38063459

IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro

Q39079705

In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors

Q39329400

A semi-autonomous model of endochondral ossification for developmental tissue engineering

Q39384576

The effect of both a thoracic trauma and a soft-tissue trauma on fracture healing in a rat model

Q39720555

Interleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells

Q39836740

The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines.

Q40285708

A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells

Q41735342

Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing

Q43250061

Cyclooxygenase-2 inhibitor inhibits the fracture healing

Q44255707

Influence of pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte function

Q44572438

Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes.

Q46955692

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

copyrighted

issue

main subject

rheumatoid arthritis

Q187255

P304

page(s)

226-235

P577

publication date

2016-04-06

P1433

published in

Connective Tissue Research

Q15755653

P1476

title

Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cells

P478

volume